Small round cell tumors of bone

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 2, 2007, Pages 192-204

  Hameed, Meera ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; BONE BIOPSY; BONE CANCER; BONE RADIOGRAPHY; BONE TUMOR; CANCER SURVIVAL; CHILD; CHONDROSARCOMA; CHROMOSOME TRANSLOCATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DIAGNOSTIC IMAGING; EWING SARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MESENCHYMOMA; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PROGNOSIS; REVIEW; SMALL CELL SARCOMA; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHONDROSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROECTODERMAL TUMORS, PRIMITIVE; OSTEOSARCOMA; PROGNOSIS; SARCOMA, EWING'S; TREATMENT OUTCOME;

EID: 33846949677     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Stout AP. A tumor of the ulnar nerve. Proc N Y Pathol Soc. 1918;12:2-12.
2. Ewing J. Diffuse endothelioma of bone. Proc N Y Pathol Soc. 1921;21:17-24.
3. Cohn I. Epithelial neoplasms of peripheral and cranial nerves. Report of three cases: review of the literature. Arch Surg. 1928;17:117-160.
4. Angerwall L, Enzinger FM. Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer. 1975;36:240-251.
5. Jaffe R, Santamaria M, Yunis EJ, et al. The neuroectodermal tumor of bone. Am J Surg Pathol. 1990;8:885-898.
6. Ushigome U, Machinami R, Sorensen PH. Ewing sarcoma/primitive neuroectodermal tumor (PNET). In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:298-300. World Health Organization Classification of Tumours.
7. Turc-Carel C, Philip I, Berger MP, Phili T, Lenoir GM. Chromosomal translocations in Ewing's sarcoma. N Engl J Med. 1983;309:497-498.
8. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med. 1984;311:584-585.
9. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States: sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995;75:2186-2195.
10. Carvajal R, Meyers P. Ewing's sarcoma and primitive neuroectodermal family of tumors. Hematol Oncol Clin North Am. 2005;19:501-525.
11. Fizazi K, Dohollou N, Blay JY, et al. Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol. 1998;16:3736-3743.
12. Levine RG, Bono CM, Hameed M, et al. Ewing sarcoma in an octogenarian: a case report. J Bone J Surg Am. 2002;84:445-448.
13. Dorfman H, Czerniak B. Bone cancers. Cancer. 1995;75(suppl):203- 210.
14. Himelstein BP, Dormans JP. Malignant bone tumors of childhood. Pediatr Clin North Am. 1996;43:967-983.
15. Widhe B, WidheT. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am. 2000;82:667-674.
16. Wagner LM, Neel MD, Pappo AS, et al. Fractures in pediatric Ewing sarcoma. J Pediatric Hematol Oncol. 2001;23:568-571.
17. Hoffer FA. Primary skeletal neoplasms: osteosarcoma and Ewing sarcoma. Top Magn Reson Imaging. 2002;13:231-240.
18. Nascimento AG, Unni K, Pritchard D, Cooper KL, Dahlin DC. A clinicopathological study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone. Am J Surg Pathol. 1980;4:29-36.
19. Julia BA, Fidler ME, James NR, et al. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol. 1999;23:159-165.
20. Hauben E, van den Broek LC, Van Marck E, Hogendoorn PC. Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma: the t(11;22),t(12;22) status. J Pathol. 2001;195:218-221.
21. Folpe AL, Goldblum JR, Rubin BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors. Am J Surg Pathol. 2005;29:1025-1033.
22. Suh CH, Ordonez NG, Hicks J, Mackay B. Ultrastructure of the Ewing's sarcoma family of tumors. Ultrastruct Pathol. 2002;26:67-76.
23. Franchi A, Pasquinelli G, Cenacchi G, et al. Immunohistochemical and ultrastructural investigation of neural differentiation in Ewing sarcoma/PNET of bone and soft tissues. Ultrastruct Pathol. 2001;25:219-225.
24. Ambros IM, Ambras PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors: evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer. 1991;67:1886-1893.
25. Bantig GS, Pym B, Darling SM, Goodfellow PN. The MIC2 gene product: epitope mapping and structural prediction analysis define an integral membrane protein. Mol Immunol. 1989;26:181-188.
26. Darling SM, Goodfello PJ, Pym B, Banting GS, Pritchard C, Goodfellow PN. Molecular genetics of MIC2: a gene shared by the human X and Y chromosomes. Cold Spring Harb Symp Quant Biol. 1986;51:205-212.
27. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26:1175-1183.
28. Lae ME, Roche PC, Jin L, Lloyd RV, Nascimento AG. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical and molecular study of 32 tumors. Am J Surg Pathol. 2002;26:823-835.
29. Ozdemirli M, Fanburg-Smith JC, Hartmann DP, Azumi N, Miettinen M. Differentiating lymphoblastic lymphoma and Ewing's sarcoma:lymphocyte markers and gene arrangement. Mod Pathol. 2001;14:1175-1182.
30. Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol. 1996;27:1273-1276.
31. Llombart-Bosch A, Navarro S. Immunohistochemical detection of EWS and FLI-1 proteins in Ewing sarcoma and primitive neuroectodermal tumors:comparative analysis with CD99 (MIC-2) expression. Appl Immmunohistochem Mol Morphol. 2001;9:255-260.
32. Fellinger EJ, Garin-Chesa P, Glasser DB, Huvos AG, Rettig WJ. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase and vimentin in the immunohistochemical study of Ewing's sarcoma of bone. Am J Surg Pathol. 1992;16:746-755.
33. Amann G, Zoubek A, Salzer-Kuntschik M, Windhager R, Kovar H. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing Family. Hum Pathol. 1999;30:1058-1064.
34. Gu M, Antonesu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MF. Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol. 2000;24:410-416.
35. Aurias A, Rimbaut C, Buffe C, Dubousset J, Mazabraud A. Chromosomal translocations in Ewing's sarcoma. N Engl J Med. 1983;309:496-497.
36. Miozzo M, Sozzi G, Calderone C, et al. t(11;22) in three cases of peripheral neuroepithelioma. Genes Chromosomes Cancer. 1990;:2:163-165.
37. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med. 1984;311:584-585.
38. May WA, Gishizky ML, Lessnik SL, et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A. 1993;90:5752-5756.
39. Sorensen PH, Lessnick SL, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994;6:146-151.
40. Jeon IS, Davis JN, Braun BS, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995;10:1229-1234.
41. Kaneko Y, Yoshida K, Handa M, et al. Fusion of an ETS-family gene, E1AF, to EWS by t(7;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer. 1996;15:115-121.
42. Urano F, Umezawa A, Hong W, et al. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun. 1996;219:608-612.
43. Peter M, Couturier J, Pacquement H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 1997;14:1159-1164.
44. Ohno T, Ouchida M, Lee L, et al. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft tumors and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene. 1994;9:3087-3097.
45. Rossow KL, Janknecht R. The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res. 2001;61:2690-2695.
46. Aman P, Panagopoulos I, Lassen C, et al. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics. 1996;37:1-8.
47. Sementchenko VI, Watson DK. Ets target genes: past, present and future. Oncogene. 2000;19:6533-6548.
48. Folpe A, Chand EM, Goldblum JR, et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25:1061-1066.
49. Kovar H. Context matters: the hen or egg problem in Ewing's sarcoma. Semin Cancer Biol. 2005;15:189-196.
50. Amandine HLT, Yaacov BD. The role of Fli-1 in normal cell function and malignant transformation. Oncogene. 2000;19:6482-6489.
51. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 1993;12:4481-4487.
52. Kovar H. Ewing tumor biology: perspectives for innovative treatment approaches. Adv Exp Med Biol. 2003:27-37.
53. Peter M, Gilbert E, Delattre O. A multiplex real-time PCR assay for the detection of gene fusions observed in solid tumors. Lab Invest. 2001;81:905-912.
54. Xiang Q, Long J, Brandon S, Rhett PK, Syed J, Ricardo L. Molecular diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffin-embedded tissues by RT-PCR and fluorescence in situ hybridization. Diagn Mol Pathol. 14:23-28.
55. Udayakumar AM, Sundareshan TS, Mallana GT, et al. Cytogenetic characterization of Ewing tumors using fine needle aspiration samples: a 10 year experience and review of literature. Cancer Genet Cytogenet. 2001;127:42-48.
56. Udayakumar AM, Sundareshan TS. Cytogenetic characterization of Ewing tumors: further update on 20 cases [letter]. Cancer Genet Cytogenet. 2002;133:102-103.
57. Rodiguez-Galindo C. Pharmacological management of Ewing sarcoma family of tumours. Expert Opin Pharmacother. 2004;17:329a.
58. Carpentieri DF, Qualman SJ, Bowen J, Krausz T, Marchevsky A, Dickman PS. Protocol for the examination of the specimens from pediatric and adult patients with osseous and extraosseous Ewing sarcoma family of tumors, including peripheral primitive neuroectodermal tumor and Ewing sarcoma. Arch Pathol Lab Med. 2005;129:866-873.
59. Schoedel K, Dickman PS, Krailo M, Perlman EJ, Miser J, Grier H. Histologic response to chemotherapy and prognosis in osseous Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) [abstract]. Int Surg Pathol. 1995;2(suppl):443.
60. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing's sarcoma study group. J Clin Oncol. 2000;18:3108-3114.
61. Delepine N, Delepine G, Cornille H, Voisin MC, Brun B, Desbois JC. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. J Chemother. 1997;9:352-363.
62. Picci P, Rougraff BT, Bacci G, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of extremities. J Clin Oncol. 1993;11:1763-1769.
63. Burchill SA. Ewing's sarcoma: diagnostic, prognostic and therapeutic implications of molecular abnormalities. J Clin Pathol. 2003;56:96-102.
64. Amiel A, Ohali A, Fejgin M, et al. Molecular cytogenetic parameters in Ewing sarcoma. Cancer Genet Cytogenet. 2003;140:107-112.
65. Zoubek A, Dockhorn-Dwarniczak B, Delatire O, et al. Does expression of different EWS transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol. 1996;14:245-251.
66. Lin PP, Brody RJ, Hamelin AC, et al. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res. 1999;59:1428-1455.
67. Fagnou C, Michon J, Peter M, et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor: Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 1998;16:1707-1711.
68. Zoubek A, Ladenstein R, Windhager R, et al. Predictive potential of testing for bone marrow involvement in Ewing's tumor patients by RT-PCR: a preliminary evaluation. Int J Cancer. 1998;79:56-60.
69. West DC, Grier HE, Swallow MM, et al. Detection of circulating tumor cells in patients with Ewing's sarcoma and primitive peripheral neuroectodermal tumor. J Clin Oncol. 1997;15:583-588.
70. Schleiermacher G, Peter M, Oberlin O, et al. Increased risk of systemic relapses associated with bone marrow micrometastases and circulating tumor cells in localized Ewing's tumor. J Clin Oncol. 2003;21:85-91.
71. Kennedy JG, Frelinghuysen P, Hoang BH. Ewing sarcoma: current concepts in diagnosis and treatment. Curr Opin Pediatr. 2003;15:53-57.
72. Kovar J, Aryee D, Zoubek A. The Ewing family of tumors and the search for the Achilles' heel. Curr Opin Oncol. 1999;11:275-292.
73. Prieur A, Tirode F, Cohen P, et al. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol. 2004;24:7275-7283.
74. Ouchida M, Ohno T, Fujimara Y, et al. Loss of tumorigenecity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene. 1995;11:1049-1054.
75. Parker F, Jackson H Jr. Primary reticulum cell sarcoma of bone. Surg Gynecot Obstet. 1939;68:45-53.
76. Oberling C. Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcoma d'Ewing). Bull Assoc Fr Etude Cancer (Paris). 1928;17:259-296.
77. Unni KK, Hogendoorn PCW. Malignant lymphoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002. World Health Organization Classification of Tumours.
78. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;28:252-260.
79. Rodman D, Raymond AK, Phillips WC. Case report 201: primary lymphoma of bone (PLB) - left fibula. Skeletal Radiol. 1982;8:235-237.
80. Rosenberg SA, Diamond HD, Jasowitz B, Craver LF. Lymphosarcoma: a review of 1269 cases. Medicine. 1961;40:31-81.
81. Rudder RA, Ross ME, De Lellis RA. Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer. 1978;42:406-416.
82. Heyning FH, Hogendoorn PC, Kramer MN, et al. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia. 1999;13:2094-2098.
83. Barr J, Burkes RL, Bell R, Blackstein M, Fernandes B, Langer F. Primary non-Hodgkin's lymphoma of bone. Cancer. 1994;73:1194-1199.
84. Dubey P, Chul SH, Besa P, et al. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys. 1997;37:1087-1093.
85. Moses AM, Spencer H. Hypercalcemia in patients with malignant lymphoma. Ann Int Med. 1963;59:531-536.
86. Dorfman H, Cherniak B. Bone Tumors. St Louis, Mo: Mosby; 1998.
87. Braunstein EM, White SJ. Non-Hodgkin's lymphoma of bone. Radiology. 1980;135:59-63.
88. Clayton F, Butler JJ, Ayala AG, Ro JY, Zornoza J. Non-Hodgkin's lymphoma in bone. Cancer. 1987;60:2494-2501.
89. Mulligan ME, McRae GA, Murphy MD. Imaging features of primary lymphoma of bone. Amer J Radiol. 1999;173:1691-1697.
90. Ozdemirli M, Fanburg-Smith J, Hartmann DP, et al. Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature. Am J Surg Pathol. 1998;22:795-804.
91. Takemoto S, Matsuoka M, Sakata K, et al. Primary adult T cell leukemia of bone: two patients with primary bone lesion showing monoclonal integration of HTLV-1 proviral DNA. Leukemia. 1996;10:333-337.
92. Antillon F, Behm FG, Raimondi SC, Kaste SC, Sandland JT, Pappo AS. Pediatric primary diffuse large cell lymphoma of bone with t(3;22)(q27;q11). J Pediatr Hematol Oncol. 1998;20:552-555.
93. Misgeld E, Wehmeier A, Kromeke O, Gattermann N. Primary non-Hodgkin's lymphoma of bone: three cases and a short review of the literature. Ann Hematol. 2003;82:440-443.
94. Ostowski M, Unni KK, Banks PM, et al. Malignant lymphoma of bone. Cancer. 1986;58:2646-2655.
95. Mendenhall NP, Jones JJ, Kramer BS, et al. The management of primary lymphoma of bone. Radiother Oncol. 1987;8:137-145.
96. Lichtenstein L, Bernstein D. Unusual benign and malignant chondroid tumors of bone. Cancer. 1959;12:1142-1157.
97. Dahlin DC, Henderson ED. Mesenchymal chondrosarcoma: further observations on a new entity. Cancer. 1962;15:410-417.
98. Bertoni F, Picci P, Bacchini P. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer. 1983;52:533-541.
99. Nakashima Y, Unni KK, Shives TC, Sweet RG, Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue: a review of 111 cases. Cancer. 1986;57:2444-2453.
100. Dabska M, Huvos AG. Mesenchymal chondrosarcoma in the young: a clinicopathological study of 19 patients with explanation of histogenesis. Virchows Arch Pathol Histopathol. 1983;399:89-104.
101. Salvador AH, Beabout JW, Dahin DC. Mesenchymal chondrosarcoma: observation on 30 new cases. Cancer. 1971;28:605-616.
102. Harwood AR, Krajbich JI, Fornasier VL. Mesenchymal chondrosarcoma: a report of 17 cases. Clin Orthop Relat Res. 1981;158:144-148.
103. Zura RD, Minasi JS, Kahler DM. Tumor-induced osteomalacia and symptomatic looser zones secondary to mesenchymal chondrosarcoma. J Surg Oncol. 1999;71:58-62.
104. Shinaver GN, Mafee MF, Choi KH. MRI of mesenchymal chondrosarcoma of the orbit: case report and review of literature. Neuroradiology. 1997;39:296-301.
105. Ariyoshi Y, Shimahara D. Mesenchymal chondrosarcoma of the maxilla: report of a case. J Oral Maxillofac Surg. 1999;57:733-737.
106. Steiner GC, Mirra JM, Bullough PG. Mesenchymal chondrosarcoma: a study of the ultrastucture. Cancer. 1973;32:926-939.
107. Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol. 1996;27:1273-1276.
108. Aigner T, Loos S, Muller S, Sandell LJ, Unni KK, Kirshner T. Cell differentiation and matrix gene expression in mesenchymal chondrosarcoma. Am J Pathol. 2000;156:1327-1335.
109. Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small round cell tumors. Hum Pathol 2003;34:263-269.
110. Ng LJ, Wheatley S, Muscat GEO, et al. Sox9 binds DNA, activates transcription and co express with type II collagen during chondrogenesis in mouse. Dev Biol. 1997;183:108-121.
111. Bi W, Deng JM, Zhang Z, et al. Sox9 is required for cartilage formation. Nat Genet. 1999;22:85-89.
112. Dobin SM, Donner LR, Speights VO Jr. Mesenhymal chondrosarcoma: a cytogeentic, immunohistochemical and ultrastructural study. Cancer Genet Cytogenet. 1005;83:56-60.
113. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge JA. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol. 2002;15:572-576.
114. Sainati L, Scapinello A, Montaldi A, et al. Mesenchymal chondrosarcoma of a child with reciprocal translocation (11;22)(q24;q12), Cancer Genet Cytogenet. 1993;71:144-147.
115. Park YK, Park HR, Chi SG, et al. Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma. Oncol Rep. 2000;7:1041-1047.
116. Bae DK, Park YK, Chi SG, Lee CW, Unni KK. Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcoma. Oncol Res. 2000;12:5-10.
117. Brown RE, Boyle JL. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach with morphogenic and therapeutic implications. Ann Clin Lab Sci. 2003;33:131-141.
118. Dowling EA. Mesenchymal chondrosarcoma. J Bone Joint Surg. 1964;46-A:747-754.
119. Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer. 1998;82:2350-2355.
120. Nussbeck W, Neureiter D, Soder S, Inwards C, Aigner T. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation. Pathology. 2004;36:230-233.
121. Sim FH, Unni KK, Beabout JW, Dahlin DC. Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg Am. 1979;61:207-215.
122. Dahlin DC, Unni KK. General Aspects and Data on 11087 Cases. 5th ed. Philadelphia, Pa: Lippincott-Raven, 1996.
123. Ayala AG, Ro JY, Raymond K, et al. Small cell osteosarcoma: a clinicopathologic study of 27 cases. Cancer. 1989;64:2162-2173.
124. Ayala AG, Ro JY, Papadopoulos NK, Raymond KA, Edeiken J. Osteosarcoma in Adolescents and Young Adults. Boston, Mass: Kluwer Academic Publishers; 1993.
125. Nakajima H, Sim FH, Bond JR, Unni KK. Small cell osteosarcoma of bone: review of 72 cases. Cancer. 1997;79:2095-2106.
126. Park SH, Kim I. Small cell osteogenic sarcoma of the ribs: cytological, immunohistochemical and ulttrastructural study with literature review. Ultra Pathol. 1999;23:133-140.
127. Bertoni F, Present D, Bacchini P, Pignatti G, Picci P, Campanacci M. The Instituto Rizzoli experience with small cell osteosarcoma. Cancer. 1989;64:2591-2599.
128. Martin SE, Dwyer A, Kissane TJ. Small cell osteosarcoma. Cancer. 1982;50:990-996.
129. Devoe K, Weidner N. Immunohistochemistry of small round cell tumors. Semin Diagn Pathol. 2000;17:216-224.
130. Devaney K, Vinh TN, Sweet DE. Small cell osteosarcoma: an immunohistochemical study with differential diagnostic considerations. Hum Pathol. 1993;24:1211-1225.
131. Thomas F, Lipton J, Barbera C, Vigorita V, Bryk E. Primary rhabdomyosarcoma of the humerus: a case report and review of the literature. J Bone Joint Surg Am. 2002;84-A:813-817.
132. Murphy A, Stallings RL, Howard J, et al. Primary desmoplastic small round cell tumor of bone: report of a case with cytogenetic confirmation. Cancer Genet Cytogenet. 2005;156:167-171.
133. Pappo AS, Douglass EC, Meyer WH, et al. Use of HBA-71 and anti-beta microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol. 1993;24:880-885.